Genprex (stock symbol: GNPX) Logo in transparent PNG format

Genprex Logo large

Genprex Logo icon format

About Genprex

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

  • Website domain:
  • Employees: 17
  • Marketcap: $46.77 Million USD

Page last updated on:

November 22nd, 2020